Abstract

The study is intended to evaluate the pharmacological activities, isolation and characterization of the bioactive phytochemical constituents from the crude leaf extract of Sterculia urens Roxb. The extraction of the phytochemicals from the leaves was carried on Soxhlet extraction apparatus using solvents like hexane, ethyl acetate, methanol and water. Pharmacological activities such as DPPH free radical scavenging assay (antioxidant), α-amylase inhibition assay (antidiabetic), albumin denaturation assay (antiinflammatory), blood clot lysis method (thrombolytic) and well diffusion method (antibacterial) of the crude extracts were evaluated and then the semi-preparative HPLC analysis followed by spectral studies was carried for the purification and identification of bioactive compounds. The methanolic extract showed high DPPH radical scavenging activity, α-amylase inhibition activity and albumin denaturation inhibition activity with IC50 values of 29.51±0.11, 146.85±0.18 and 149.91±0.19 μg/mL respectively. The % clot lysis of the methanolic extract was found higher than the other extracts and all the extracts have potential inhibition on the growth of the bacterial studied. From the leaf methanolic extract, 4 phenolic compounds (2,4-dihydroxybenzoic acid, methyl 4- hydroxycinnamate, p-coumaric acid and stercurensin) and 3 phenolic compounds (gossypetin, farrerol and quercetin 5,7,3',4'-tetramethyl ether) were isolated and characterised. Based on the results observed, it can be concluded that the leaf extracts of Sterculia urens Roxb are having rich phytochemical constituents with prominent pharmacological activities.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call